LeadInvent Pharma Inc

Headquarters

Unknown, US

LeadInvent Pharma Inc. is a nano-medicine company developing GBGel, a gel formulation for enhancing brain cancer surgery. The company manufactures a medical-grade gel loaded with light-sensitive nanoparticles to kill leftover cancer cells during surgery, targeting brain cancer markets.

• Duo OncologyDuo Oncology is a clinical-stage biotechnology company that develops and manufactures ultrasmall nanomedicines for cancer treatment. The company's proprietary platform creates nanomedicines that deliver dual anti-cancer therapies directly to tumors, with a lead product DUO-207 for pancreatic cancer advancing to clinical trials.PITTSBURGH, PA
• Nanobrid Innovations Private LimitedNanobrid Innovations Private Limited is a pharmaceutical manufacturing company that develops a proprietary next-generation lipid-polymer hybrid nanotechnology platform. The platform enables delivery of difficult-to-deliver active ingredients across various therapeutic areas and clinical indications, with flexibility for multiple routes of administration such as topical, injectables, ocular, and nasal.RAJASTHAN, IN
• NEXGEL, IncNEXGEL, Inc. is an FDA registered and ISO certified manufacturer of ultra-gentle, high-water-content hydrogels for transdermal drug delivery, wound care, and cosmetic applications. The company operates a 16,500 sq ft cGMP manufacturing facility with R&D and converting capabilities, using proprietary electron-beam cross-linking technology.LANGHORNE, PA
• IA
  InnovaGel, a KD Pharma Group CompanyInnovaGel is a KD Pharma Group company specializing in soft gelatin capsules, vegetarian softgels, contract manufacturing and packaging, product development and formulations, dietary supplements, and OTC products.MIAMI, FL